Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001171843-13-000605)

Filing Details

Accession Number:: 0001171843-13-000605
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2013-02-14 20:29:23
Reporting Period:: 2012-12-31

Filing Date:: 2013-02-14
Accepted Time:: 2013-02-14 20:29:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1318641	Cleveland Biolabs Inc	CBLI	Services-Commercial Physical & Biological Research (8731)	200077155

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1315696	James Antal	C/O Cleveland Biolabs, Inc. 73 High Street Buffalo NY 14203		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.005 Per Share	Acquisiton	2012-12-27	4,300	$1.35	4,300	No	4	P	Indirect	Held by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.005 Per Share	27,258	Direct

Footnotes

The transaction reported in this Form 5 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2011 and these shares are held by a trust of which the reporting person is a trustee.